EARNINGS FORECAST TABLE: GlaxoSmithKline 2Q 2012
07/19/2012| 11:26am US/Eastern
Recommend:
FRANKFURT--The following is a summary of analysts' forecasts for GlaxoSmithKline plc (>> GlaxoSmithKline plc) second-quarter results, based on a poll of nine analysts conducted by Dow Jones Newswires (figures in million pound, EPS, dividend and target price in pence, according to IFRS). Earnings figures are scheduled to be released July 25 at 1100 GMT.
===
Core Core
Turnover Turnover operat. Pretax
2nd Quarter total Advair profit profit
AVERAGE 6,646 1,264 2,034 1,866
Prev. Year 6,720 1,270 2,167 1,981
+/- in % -1.1 -0.5 -6.2 -5.8
MEDIAN 6,655 1,263 2,036 1,864
Maximum 6,741 1,295 2,089 1,891
Minimum 6,456 1,241 1,964 1,845
Amount 9 8 9 5
Barclays Capital 6,676 1,253 2,049 --
Bernstein 6,655 1,262 2,025 1,864
BoA-Merrill Lynch 6,699 1,241 2,036 1,864
Citigroup 6,700 1,295 2,022 1,865
Deutsche Bank 6,614 1,264 2,020 1,845
Helvea 6,615 1,268 2,089 --
J.P. Morgan 6,456 1,260 1,964 --
Nomura 6,655 1,267 2,042 1,891
UBS 6,741 -- 2,055 --
Core
Net attrib. Core
2nd Quarter profit EPS
AVERAGE 1,341 26.9
Prev. Year 1,413 27.9
+/- in % -5.1 -3.6
MEDIAN 1,331 26.9
Maximum 1,381 27.5
Minimum 1,307 26.0
Amount 7 9
Barclays Capital 1,358 27.5
Bernstein 1,381 27.0
BoA-Merrill Lynch 1,331 26.9
Citigroup 1,331 26.9
Deutsche Bank 1,307 26.4
Helvea 1,328 26.9
J.P. Morgan -- 26.0
Nomura 1,350 27.3
UBS -- 27.1
Target price Rating DPS 2012
AVERAGE 1,589 positive 4 AVERAGE 74.9
Prev. Quarter 1,483 neutral 4 Prev. Year 75.0
+/- in % +7.2 negative 0 +/- in % -0.1
MEDIAN 1,599 MEDIAN 74.5
Maximum 1,750 Maximum 77.0
Minimum 1,400 Minimum 73.7
Amount 8 Amount 4
Barclays Capital 1,575 Equalweight 75.0
Bernstein 1,588 Marketperform --
BoA-Merrill Lynch 1,750 Buy 73.7
Citigroup 1,610 Buy 77.0
Deutsche Bank 1,400 Hold 74.0
Helvea 1,620 Accumulate --
J.P. Morgan 1,470 Neutral --
UBS 1,700 Buy --
===
Year-earlier figures are as given by the company.
DJG/err
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Recommend :
